Abbott Laboratories buy UBS Group AG
Start price
17.10.24
/
50%
€108.52
Target price
17.10.25
€134.85
Performance (%)
1.35%
End price
18.10.25
€109.98
Summary
This prediction ended on 18.10.25 with a price of €109.98. The BUY prediction by UBS_Group_AG finished with a performance of 1.35%. Dividends of €0.57 are taken into consideration when calculating the performance. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | -2.391% | -2.391% | -23.940% |
| iShares Core DAX® | 4.244% | 2.864% | 14.030% |
| iShares Nasdaq 100 | 4.890% | 2.814% | 32.707% |
| iShares Nikkei 225® | 9.397% | 7.826% | 48.296% |
| iShares S&P 500 | 3.528% | 1.950% | 25.247% |
Comments by UBS_Group_AG for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at UBS Group AG from $143.00 to $146.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Stopped prediction by UBS_Group_AG for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€113.50
23.01.25
23.01.25
€142.08
23.01.26
23.01.26
-19.76%
24.01.26
24.01.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.04
20.04.23
20.04.23
€118.42
20.04.24
20.04.24
-1.53%
21.04.24
21.04.24